இணை தலைமை புலனாய்வாளர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இணை தலைமை புலனாய்வாளர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இணை தலைமை புலனாய்வாளர் Today - Breaking & Trending Today

Blood cancer clinical trial includes Cardiff and Vale UHB | Barry And District News


Stock photo of doctor and patient
A NEW clinical trial could lead to less toxic treatment for blood cancer.
Cardiff and Vale University Health Board is implementing a new clinical trial which will give blood cancer patients access to a promising, active lower intensity treatment option.
The VICTOR clinical trial, which is funded by Cancer Research UK and led by Dr Richard Dillon from Guy’s Hospital in London, will examine the efficacy of venetoclax-based treatment in treating certain groups of older patients with acute myeloid leukaemia (AML).
If found to be effective, the treatment could spare future patients some of the more toxic effects of traditional intensive chemotherapy. ....

United Kingdom , City Of , Steve Knapper , Richard Dillon , Haematology Clinical Research Group In Cardiff , Clinical Research Facility , Vale University Health Board Research , Cancer Research United Kingdom , Development Department , Trials Acceleration Programme , Care Research Wales , Cure Leukaemia , Clinical Reader , Cardiff University School , Co Chief Investigator , Haematology Clinical Research Group , Vale University Health Board , Welsh Government , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , ஸ்டீவ் க்னப்பேர் , ரிச்சர்ட் டில்லன் , ஹீமாட்டாலஜி மருத்துவ ஆராய்ச்சி குழு இல் கார்டிஃப் , மருத்துவ ஆராய்ச்சி வசதி , வேல் பல்கலைக்கழகம் ஆரோக்கியம் பலகை ஆராய்ச்சி , புற்றுநோய் ஆராய்ச்சி ஒன்றுபட்டது கிஂக்டம் ,

New trial to look at reducing transmission of Covid-19 in care homes


New trial to look at reducing transmission of Covid-19 in care homes
A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research (NIHR).
The team are initially looking for up to 400 care homes to take part in the ground-breaking trial - called PROTECT.
As part of the trial, researchers will test drugs that already show promise for treating Covid-19, but will use them to prevent Covid-19 instead. The team will focus on care home residents because they are at high risk from Covid-19, and although priority has been given to them for vaccination, the effectiveness of vaccines in this group has not yet been fully established. The aim is to reduce the number and severity of Covid-19 cases in those homes. ....

United Kingdom , City Of , Adam Gordon , Vic Rayner , Emily Henderson , University College London , Queen University Belfast , National Institute For Health Research , University Of Nottingham , British Geriatrics Society , National Care Forum , National Institute , Health Research , Professor Philip Bath , University Belfast , University College , Co Chief Investigator , Executive Director , Innovation Lord Bethell , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , பண்படாமனித இயல்பு கோர்டந் , விக் ரேநர் , எமிலி ஹென்டர்சன் , பல்கலைக்கழகம் கல்லூரி லண்டன் , ராணி பல்கலைக்கழகம் பெல்ஃபாஸ்ட் ,

Covid Treatment | Steroid use in COVID treatment, Dexamethasone, should be avoided in patients with chronic subdural haematoma


Updated Dec 17, 2020 | 11:50 IST
Dexamethasone is a steroid that decreases the body’s natural defensive response and decreases inflammation such as swelling and allergic-type reactions, used as a treatment for chronic subdural haematoma.
Steroid use in COVID treatment, Dexamethasone, should be avoided in patients with chronic subdural haematoma  |  Photo Credit: iStock Images
Key Highlights
Dexamethasone became a popular COVID-19 treatment, after it showed efficacy and safety in severe cases of infection
Dexamethasone has been used as a common treatment for chronic subdural haematoma since 1970s
A recent study has however found that use of dexamethasone for chronic subdural haematoma may have worse outcomes than no medication given for the condition ....

United Kingdom , New Delhi , Angelos Kolias , Ellie Edlmann , Peter Hutchinson , University Of Cambridge , British Neurosurgical Trainee Research Collaborative , University Of Plymouth , Photo Credit , Stock Images , Essential Medicines , Chronic Subdural Haematoma , New England Journal , Co Chief Investigator , Clinical Lecturer , ஒன்றுபட்டது கிஂக்டம் , புதியது டெல்ஹி , பீட்டர் ஹட்சின்சன் , பல்கலைக்கழகம் ஆஃப் கேம்பிரிட்ஜ் , பிரிட்டிஷ் நரம்பியல் அறுவை சிகிச்சை பயிற்சி ஆராய்ச்சி கூட்டு , பல்கலைக்கழகம் ஆஃப் ப்லிமத் , புகைப்படம் கடன் , ஸ்டாக் படங்கள் , அவசியம் மருந்துகள் , புதியது இங்கிலாந்து இதழ் , இணை தலைமை புலனாய்வாளர் ,